“…Abrupt cessation can also cause a discontinuation syndrome. These data further show that TCAs, especially doxepin, also decreased symptoms of anxiety in this group (Kleber et al, 1983;Titievsky, Seco, Barranco, & Kyle, 1982;Woody, O'Brien, & Rickels, 1975;Woody, O'Brien, McLellan, Marcovici, & Evans, 1982). TCAs should be avoided in patients at risk of suicide (Nutt, 2005b).…”